Interruptions in Antiretroviral Treatment Increases Risk of Developing AIDS-Related Diseases, Can Be Fatal, Study Says
reviews the publication, in the New England Journal of Medicine of the SMART study--- Strategies for Management of Antiretroviral Therapy. Led by NIH and involving 5,472 HIV-positive people in 33 countries , it began in January 2002 but was halted at the beginning of this year after preliminary results indicated that the mortality rates among the 2,720 participants who were in the treatment-interruption group were significantly higher.
We looked at Poz’s and Aidsmap’s coverage of this issue in
Meds Break? (Tuesday November 7, 2006)